Viewing Study NCT02185820


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-06-15 @ 8:50 PM
Study NCT ID: NCT02185820
Status: COMPLETED
Last Update Posted: 2023-07-03
First Post: 2014-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD)
Sponsor:
Organization: